TGF-β as tumor suppreβor: In vitro mechanistic aspects of growth inhibition

TGF-β in Human Disease

Volumn 9784431544098, Issue , 2013, Pages 113-138

  Bartholin, Laurent ^a   Vincent, David F ^a   Valcourt, Ulrich ^a  

^a CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

Author keywords

Apoptosis; Cell cycle regulation; Cytostasis; Posttranslational events; Smad signaling; Smad independent pathways; Transcriptional regulation

Indexed keywords

EID: 84893878051     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-4-431-54409-8_5     Document Type: Chapter

References (119)

1. Alexandrow MG, Kawabata M, Aakre M, Moses HL (1995) Overexpreβion of the c-Myc oncoprotein blocks the growth-inhibitory response but is required for the mitogenic effects of transforming growth factor-1. Proc Natl Acad Sci USA 92:3239-3243
2. Amendt C, Mann A, Schirmacher P, Bleβing M (2002) Resistance of keratinocytes to TGF-mediated growth restriction and apoptosis induction accelerates re-epithelialization in skin wounds. J Cell Sci 115:2189-2198
3. Anzano MA, Roberts AB, Sporn MB (1986) Anchorage-independent growth of primary rat embryo cells is induced by platelet-derived growth factor and inhibited by type-transforming growth factor. J Cell Physiol 126:312-318
4. Atfi A, Buisine M, Mazars A, Gespach C (1997) Induction of apoptosis by DPC4, a transcriptional factor regulated by transforming growth factor-through streβ-Activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) signaling pathway. J Biol Chem 272:24731-24734
5. Azar R, Alard A, Susini C, Bousquet C, Pyronnet S (2009) 4E-BP1 is a target of Smad4 eβential for TGF-mediated inhibition of cell proliferation. EMBO J 28:3514-3522
6. Baird A, Durkin T (1986) Inhibition of endothelial cell proliferation by type-transforming growth factor: interactions with acidic and basic fi broblast growth factors. Biochem Biophys Res Commun 138:476-482
7. Battegay EJ, Raines EW, Seifert RA, Bowen-Pope DF, Roβ R (1990) TGF-induces bimodal proliferation of connective tiβue cells via complex control of an autocrine PDGF loop. Cell 63:515-524
8. Bhowmick NA, Ghiaβi M, Aakre M, Brown K, Singh V, Moses HL (2003) TGF-induced RhoA and p160ROCK activation is involved in the inhibition of Cdc25A with resultant cell-cycle arrest. Proc Natl Acad Sci USA 100:15548-15553
9. Bouchard C, Thieke K, Maier A, Saffrich R, Hanley-Hyde J, Ansorge W, Reed S, Sicinski P, Bartek J, Eilers M (1999) Direct induction of cyclin D2 by Myc contributes to cell cycle progreβion and sequestration of p27. EMBO J 18:5321-5333
10. Bouzahzah B, Fu M, Iavarone A, Factor VM, Thorgeirβon β, Pestell RG (2000) Transforming growth factor-1 recruits histone deacetylase 1 to a p130 repreβor complex in transgenic mice in vivo. Cancer Res 60:4531-4537
11. Brenner D, Mak TW (2009) Mitochondrial cell death effectors. Curr Opin Cell Biol 21:871-877
12. Chalaux E, Lopez-Rovira T, Rosa JL, Pons G, Boxer LM, Bartrons R, Ventura F (1999) A zincfi nger transcription factor induced by TGF-promotes apoptotic cell death in epithelial Mv1Lu cells. FEBS Lett 457:478-482
13. Chen CR, Kang Y, Maβague J (2001) Defective repreβion of c-myc in breast cancer cells: A loβ at the core of the transforming growth factor-growth arrest program. Proc Natl Acad Sci USA 98:992-999
14. Chen CR, Kang Y, Siegel PM, Maβague J (2002) E2F4/5 and p107 as Smad cofactors linking the TGF-receptor to c-myc repreβion. Cell 110:19-32
15. Claaβen GF, Hann SR (2000) A role for transcriptional repreβion of p21CIP1 by c-Myc in overcoming transforming growth factor-induced cell-cycle arrest. Proc Natl Acad Sci USA 97:9498-9503
16. Conery AR, Cao Y, Thompson EA, Townsend CM Jr, Ko TC, Luo K (2004) Akt interacts directly with Smad3 to regulate the sensitivity to TGF-induced apoptosis. Nat Cell Biol 6:366-372
17. Conradt B (2009) Genetic control of programmed cell death during animal development. Annu Rev Genet 43:493-523
18. Cordenonsi M, Dupont S, Maretto S, Insinga A, Imbriano C, Piccolo S (2003) Links between tumor suppreβors: p53 is required for TGF-gene responses by cooperating with Smads. Cell 113:301-314
19. Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang XF (1995) Transforming growth factor-induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci USA 92:5545-5549
20. Donzelli M, Draetta GF (2003) Regulating mammalian checkpoints through Cdc25 inactivation. EMBO Rep 4:671-677
21. Edlund S, Bu S, Schuster N, Aspenstrom P, Heuchel R, Heldin NE, ten Dijke P, Heldin CH, Landstrom M (2003) Transforming growth factor-1 (TGF-)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-Activated kinase 1 and mitogen-Activated protein kinase kinase 3. Mol Biol Cell 14:529-544
22. Ewen ME, Sluβ HK, Whitehouse LL, Livingston DM (1993) TGF-inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell 74:1009-1020
23. Feng XH, Lin X, Derynck R (2000) Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-. EMBO J 19:5178-5193
24. Feng XH, Liang YY, Liang M, Zhai W, Lin X (2002) Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-mediated induction of the CDK inhibitor p15(Ink4B). Mol Cell 9:133-143
25. Frater-Schroder M, Muller G, Birchmeier W, Bohlen P (1986) Transforming growth factor-inhibits endothelial cell proliferation. Biochem Biophys Res Commun 137:295-302
26. Frederick JP, Liberati NT, Waddell DS, Shi Y, Wang XF (2004) Transforming growth factor-mediated transcriptional repreβion of c-myc is dependent on direct binding of Smad3 to a novel repreβive Smad binding element. Mol Cell Biol 24:2546-2559
27. Galaktionov K, Chen X, Beach D (1996) Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382:511-517
28. Gomis RR, Alarcon C, He W, Wang Q, Seoane J, Lash A, Maβague J (2006a) A FoxO-Smad synexpreβion group in human keratinocytes. Proc Natl Acad Sci USA 103:12747-12752
29. Gomis RR, Alarcon C, Nadal C, Van Poznak C, Maβague J (2006b) C/EBPbeta at the core of the TGF-cytostatic response and its evasion in metastatic breast cancer cells. Cancer Cell 10:203-214
30. Green DR, Kroemer G (2004) The pathophysiology of mitochondrial cell death. Science 305:626-629
31. Guasch G, Schober M, Pasolli HA, Conn EB, Polak L, Fuchs E (2007) Loβ of TGF-signaling destabilizes homeostasis and promotes squamous cell carcinomas in stratifi ed epithelia. Cancer Cell 12:313-327
32. Guenard V, Rosenbaum T, Gwynn LA, Doetschman T, Ratner N, Wood PM (1995) Effect of transforming growth factor-1 and-2 on Schwann cell proliferation on neurites. Glia 13:309-318
33. Hannon GJ, Beach D (1994) p15INK4B is a potential effector of TGF-induced cell cycle arrest. Nature 371:257-261
34. Heimark RL, Twardzik DR, Schwartz SM (1986) Inhibition of endothelial regeneration by type-transforming growth factor from platelets. Science 233:1078-1080
35. Heldin CH, Miyazono K, ten Dijke P (1997) TGF-signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465-471
36. Hermeking H, Rago C, Schuhmacher M, Li Q, Barrett JF, Obaya AJ, O'Connell BC, Mateyak MK, Tam W, Kohlhuber F, Dang CV, Sedivy JM, Eick D, Vogelstein B, Kinzler KW (2000) Identifi cation of CDK4 as a target of c-MYC. Proc Natl Acad Sci USA 97:2229-2234
37. Herrera RE, Makela TP, Weinberg RA (1996) TGF-induced growth inhibition in primary fi broblasts requires the retinoblastoma protein. Mol Biol Cell 7:1335-1342
38. Hofmann TG, Stollberg N, Schmitz ML, Will H (2003) HIPK2 regulates transforming growth factor-induced c-Jun NH(2)-terminal kinase activation and apoptosis in human hepatoma cells. Cancer Res 63:8271-8277
39. Holley RW, Bohlen P, Fava R, Baldwin JH, Kleeman G, Armour R (1980) Purifi cation of kidney epithelial cell growth inhibitors. Proc Natl Acad Sci USA 77:5989-5992
40. Holley RW, Armour R, Baldwin JH, Greenfi eld S (1983) Activity of a kidney epithelial cell growth inhibitor on lung and mammary cells. Cell Biol Int Rep 7:141-147
41. Huβey GS, Chaudhury A, Dawson AE, Lindner DJ, Knudsen CR, Wilce MC, Merrick WC, Howe PH (2011) Identifi cation of an mRNP complex regulating tumorigenesis at the translational elongation step. Mol Cell 41:419-431
42. Hyman KM, Seghezzi G, Pintucci G, Stellari G, Kim JH, Groβi EA, Galloway AC, Mignatti P (2002) Transforming growth factor-1 induces apoptosis in vascular endothelial cells by activation of mitogen-Activated protein kinase. Surgery 132:173-179
43. Iavarone A, Maβague J (1997) Repreβion of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-in cells lacking the CDK inhibitor p15. Nature 387:417-422
44. Iavarone A, Maβague J (1999) E2F and histone deacetylase mediate transforming growth factor-repreβion of cdc25A during keratinocyte cell cycle arrest. Mol Cell Biol 19:916-922
45. Igarashi A, Okochi H, Bradham DM, Grotendorst GR (1993) Regulation of connective tiβue growth factor gene expreβion in human skin fi broblasts and during wound repair. Mol Biol Cell 4:637-645
46. Jang CW, Chen CH, Chen CC, Chen JY, Su YH, Chen RH (2002) TGF-induces apoptosis through Smad-mediated expreβion of DAP-kinase. Nat Cell Biol 4:51-58
47. Joza N, Kroemer G, Penninger JM (2002) Genetic analysis of the mammalian cell death machinery. Trends Genet 18:142-149
48. Kang Y, Chen CR, Maβague J (2003) A self-enabling TGF-response coupled to streβ signaling: Smad engages streβ response factor ATF3 for Id1 repreβion in epithelial cells. Mol Cell 11:915-926
49. Kee BL, Rivera RR, Murre C (2001) Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-. Nat Immunol 2:242-247
50. Kehrl JH, Roberts AB, Wakefi eld LM, Jakowlew S, Sporn MB, Fauci AS (1986a) Transforming growth factor-is an important immunomodulatory protein for human B lymphocytes. J Immunol 137:3855-3860
51. Kehrl JH, Wakefi eld LM, Roberts AB, Jakowlew S, Alvarez-Mon M, Derynck R, Sporn MB, Fauci AS (1986b) Production of transforming growth factor-by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 163:1037-1050
52. Kim JW, Kim HS, Kim IK, Kim MR, Cho EY, Kim HK, Lee JM, Namkoong SE (1998) Transforming growth factor-1 induces apoptosis through down-regulation of c-myc gene and overexpreβion of p27Kip1 protein in cervical carcinoma. Gynecol Oncol 69:230-236
53. Koff A, Ohtsuki M, Polyak K, Roberts JM, Maβague J (1993) Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-. Science 260:536-539
54. Koinuma D, Tsutsumi S, Kamimura N, Taniguchi H, Miyazawa K, Sunamura M, Imamura T, Miyazono K, Aburatani H (2009) Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor-signaling. Mol Cell Biol 29:172-186
55. Kowanetz M, Valcourt U, Bergstrom R, Heldin CH, Moustakas A (2004) Id2 and Id3 defi ne the potency of cell proliferation and differentiation responses to transforming growth factor-And bone morphogenetic protein. Mol Cell Biol 24:4241-4254
56. Kroemer G, Galluzzi L, Brenner C (2007) Mitochondrial membrane permeabilization in cell death. Physiol Rev 87:99-163
57. Lafon C, Mathieu C, Guerrin M, Pierre O, Vidal S, Valette A (1996) Transforming growth factor-1-induced apoptosis in human ovarian carcinoma cells: protection by the antioxidant N-Acetylcysteine and bcl-2. Cell Growth Differ 7:1095-1104
58. Laiho M, DeCaprio JA, Ludlow JW, Livingston DM, Maβague J (1990) Growth inhibition by TGF-linked to suppreβion of retinoblastoma protein phosphorylation. Cell 62:175-185
59. Lasorella A, Iavarone A, Israel MA (1996) Id2 specifi cally alters regulation of the cell cycle by tumor suppreβor proteins. Mol Cell Biol 16:2570-2578
60. Lasorella A, Noseda M, Beyna M, Yokota Y, Iavarone A (2000) Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature 407:592-598
61. Lavrik IN, Krammer PH (2012) Regulation of CD95/Fas signaling at the DISC. Cell Death Differ 19:36-41
62. Leof EB, Proper JA, Goustin AS, Shipley GD, DiCorleto PE, Moses HL (1986) Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor-: A proposed model for indirect mitogenesis involving autocrine activity. Proc Natl Acad Sci USA 83:2453-2457
63. Lin KW, Yakymovych I, Jia M, Yakymovych M, Souchelnytskyi S (2010) Phosphorylation of eEF1A1 at Ser300 by TR-I results in inhibition of mRNA translation. Curr Biol 20:1615-1625
64. Major MB, Jones DA (2004) Identifi cation of a gadd45 3 enhancer that mediates SMAD3-And SMAD4-dependent transcriptional induction by transforming growth factor-. J Biol Chem 279:5278-5287
65. Maβague J (1990) The transforming growth factor-family. Annu Rev Cell Biol 6:597-641
66. Masui T, Wakefi eld LM, Lechner JF, LaVeck MA, Sporn MB, Harris CC (1986) Type-transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Proc Natl Acad Sci USA 83:2438-2442
67. Moustakas A, Kardaβis D (1998) Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc Natl Acad Sci USA 95:6733-6738
68. Nguyen AV, Pollard JW (2000) Transforming growth factor-3 induces cell death during the fi rst stage of mammary gland involution. Development 127:3107-3118
69. Niimi H, Pardali K, Vanlandewijck M, Heldin CH, Moustakas A (2007) Notch signaling is neceβary for epithelial growth arrest by TGF-. J Cell Biol 176:695-707
70. Oberhammer FA, Pavelka M, Sharma S, Tiefenbacher R, Purchio AF, Bursch W, Schulte-Hermann R (1992) Induction of apoptosis in cultured hepatocytes and in regreβing liver by transforming growth factor-1. Proc Natl Acad Sci USA 89:5408-5412
71. Pardali K, Kurisaki A, Moren A, ten Dijke P, Kardaβis D, Moustakas A (2000) Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-. J Biol Chem 275:29244-29256
72. Pardali K, Kowanetz M, Heldin CH, Moustakas A (2005) Smad pathway-specifi c transcriptional regulation of the cell cycle inhibitor p21(WAF1/Cip1). J Cell Physiol 204:260-272
73. Parkinson DB, Dong Z, Bunting H, Whitfi eld J, Meier C, Marie H, Mirsky R, Jeβen KR (2001) Transforming growth factor-(TGF-) mediates Schwann cell death in vitro and in vivo: examination of c-Jun activation, interactions with survival signals, and the relationship of TGF-mediated death to Schwann cell differentiation. J Neurosci 21:8572-8585
74. Perk J, Iavarone A, Benezra R (2005) Id family of helix-loop-helix proteins in cancer. Nat Rev Cancer 5:603-614
75. Perlman R, Schiemann WP, Brooks MW, Lodish HF, Weinberg RA (2001) TGF-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nat Cell Biol 3:708-714
76. Pietenpol JA, Holt JT, Stein RW, Moses HL (1990a) Transforming growth factor-1 suppreβion of c-myc gene transcription: role in inhibition of keratinocyte proliferation. Proc Natl Acad Sci USA 87:3758-3762
77. Pietenpol JA, Stein RW, Moran E, Yaciuk P, Schlegel R, Lyons RM, Pittelkow MR, Munger K, Howley PM, Moses HL (1990b) TGF-1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61:777-785
78. Ramesh S, Qi XJ, Wildey GM, Robinson J, Molkentin J, Letterio J, Howe PH (2008) TGF-mediated BIM expreβion and apoptosis are regulated through SMAD3-dependent expreβion of the MAPK phosphatase MKP2. EMBO Rep 9:990-997
79. Remy I, Montmarquette A, Michnick SW (2004) PKB/Akt modulates TGF-signalling through a direct interaction with Smad3. Nat Cell Biol 6:358-365
80. Reynisdottir I, Polyak K, Iavarone A, Maβague J (1995) Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-. Genes Dev 9:1831-1845
81. Ribeiro A, Bronk SF, Roberts PJ, Urrutia R, Gores GJ (1999) The transforming growth factor-(1)-inducible transcription factor TIEG1, mediates apoptosis through oxidative streβ. Hepatology 30:1490-1497
82. Ridley AJ, Davis JB, Stroobant P, Land H (1989) Transforming growth factors-1 and-2 are mitogens for rat Schwann cells. J Cell Biol 109:3419-3424
83. Roberts AB, Lamb LC, Newton DL, Sporn MB, De Larco JE, Todaro GJ (1980) Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction. Proc Natl Acad Sci USA 77:3494-3498
84. Roberts AB, Anzano MA, Lamb LC, Smith JM, Sporn MB (1981) New claβ of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tiβues. Proc Natl Acad Sci USA 78:5339-5343
85. Rotello RJ, Lieberman RC, Purchio AF, Gerschenson LE (1991) Coordinated regulation of apoptosis and cell proliferation by transforming growth factor-1 in cultured uterine epithelial cells. Proc Natl Acad Sci USA 88:3412-3415
86. Saltzman A, Munro R, Searfoβ G, Franks C, Jaye M, Ivashchenko Y (1998) Transforming growth factor-mediated apoptosis in the Ramos B-lymphoma cell line is accompanied by caspase activation and Bcl-XL downregulation. Exp Cell Res 242:244-254
87. Sanchez-Capelo A (2005) Dual role for TGF-1 in apoptosis. Cytokine Growth Factor Rev 16:15-34
88. Sandhu C, Garbe J, Bhattacharya N, Daksis J, Pan CH, Yaswen P, Koh J, Slingerland JM, Stampfer MR (1997) Transforming growth factor-stabilizes p15INK4B protein, increases p15INK4Bcdk4 complexes, and inhibits cyclin D1-cdk4 aβociation in human mammary epithelial cells. Mol Cell Biol 17:2458-2467
89. Sano Y, Harada J, Tashiro S, Gotoh-Mandeville R, Maekawa T, Ishii S (1999) ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-signaling. J Biol Chem 274:8949-8957
90. Scandura JM, Boccuni P, Maβague J, Nimer SD (2004) Transforming growth factor-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation. Proc Natl Acad Sci USA 101:15231-15236
91. Schuster N, Krieglstein K (2002) Mechanisms of TGF-mediated apoptosis. Cell Tiβue Res 307:1-14
92. Seoane J, Pouponnot C, Staller P, Schader M, Eilers M, Maβague J (2001) TGF-infl uences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nat Cell Biol 3:400-408
93. Seoane J, Le HV, Maβague J (2002) Myc suppreβion of the p21(Cip1) Cdk inhibitor infl uences the outcome of the p53 response to DNA damage. Nature 419:729-734
94. Seoane J, Le HV, Shen L, Anderson SA, Maβague J (2004) Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117:211-223
95. Sherr CJ, Roberts JM (1999) CDK inhibitors: positive and negative regulators of G1-phase progreβion. Genes Dev 13:1501-1512
96. Shibuya H, Yamaguchi K, Shirakabe K, Tonegawa A, Gotoh Y, Ueno N, Irie K, Nishida E, Matsumoto K (1996) TAB1: An activator of the TAK1 MAPKKK in TGF-signal transduction. Science 272:1179-1182
97. Siegel PM, Shu W, Maβague J (2003) Mad upregulation and Id2 repreβion accompany transforming growth factor (TGF)-mediated epithelial cell growth suppreβion. J Biol Chem 278:35444-35450
98. Silberstein GB, Daniel CW (1987) Reversible inhibition of mammary gland growth by transforming growth factor-. Science 237:291-293
99. Soma Y, Grotendorst GR (1989) TGF-stimulates primary human skin fi broblast DNA synthesis via an autocrine production of PDGF-related peptides. J Cell Physiol 140:246-253
100. Sorrentino A, Thakur N, Grimsby S, Marcuβon A, von Bulow V, Schuster N, Zhang S, Heldin CH, Landstrom M (2008) The type I TGF-receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat Cell Biol 10:1199-1207
101. Staller P, Peukert K, Kiermaier A, Seoane J, Lukas J, Karsunky H, Moroy T, Bartek J, Maβague J, Hanel F, Eilers M (2001) Repreβion of p15INK4b expreβion by Myc through aβociation with Miz-1. Nat Cell Biol 3:392-399
102. Tachibana I, Imoto M, Adjei PN, Gores GJ, Subramaniam M, Spelsberg TC, Urrutia R (1997) Overexpreβion of the TGF-regulated zinc fi nger encoding gene, TIEG, induces apoptosis in pancreatic epithelial cells. J Clin Invest 99:2365-2374
103. Takekawa M, Tatebayashi K, Itoh F, Adachi M, Imai K, Saito H (2002) Smad-dependent GADD45 expreβion mediates delayed activation of p38 MAP kinase by TGF-. EMBO J 21:6473-6482
104. Thillainadesan G, Chitilian JM, Isovic M, Ablack JN, Mymryk JS, Tini M, Torchia J (2012) TGF-dependent active demethylation and expreβion of the p15ink4b tumor suppreβor are impaired by the ZNF217/CoREST complex. Mol Cell 46:636-649
105. Tucker RF, Shipley GD, Moses HL, Holley RW (1984) Growth inhibitor from BSC-1 cells closely related to platelet type-transforming growth factor. Science 226:705-707
106. Valcourt U, Thuault S, Pardali K, Heldin CH, Moustakas A (2007) Functional role of Meox2 during the epithelial cytostatic response to TGF-. Mol Oncol 1:55-71
107. Valderrama-Carvajal H, Cocolakis E, Lacerte A, Lee EH, Krystal G, Ali S, Lebrun JJ (2002) Activin/TGF-induce apoptosis through Smad-dependent expreβion of the lipid phosphatase SHIP. Nat Cell Biol 4:963-969
108. Varady G, Sarkadi B, Fatyol K (2011) TTRAP is a novel component of the non-canonical TRAF6-TAK1 TGF-signaling pathway. PLoS One 6:e25548
109. Vermeulen K, Van Bockstaele DR, Berneman ZN (2003) The cell cycle: A review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 36:131-149
110. Warner BJ, Blain SW, Seoane J, Maβague J (1999) Myc downregulation by transforming growth factor-required for activation of the p15(Ink4b) G(1) arrest pathway. Mol Cell Biol 19:5913-5922
111. Wildey GM, Howe PH (2009) Runx1 is a co-Activator with FOXO3 to mediate transforming growth factor-(TGF-)-induced Bim transcription in hepatic cells. J Biol Chem 284:20227-20239
112. Wildey GM, Patil S, Howe PH (2003) Smad3 potentiates transforming growth factor-(TGF)-induced apoptosis and expreβion of the BH3-only protein Bim in WEHI 231 B lymphocytes. J Biol Chem 278:18069-18077
113. Yamaguchi M, Endo H, Tasaka K, Miyake A (1995) Mouse growth hormone-releasing factor secretion is activated by inhibin and inhibited by activin in placenta. Biol Reprod 53:368-372
114. Yamashita M, Fatyol K, Jin C, Wang X, Liu Z, Zhang YE (2008) TRAF6 mediates Smadindependent activation of JNK and p38 by TGF-. Mol Cell 31:918-924
115. Yanagihara K, Tsumuraya M (1992) Transforming growth factor-1 induces apoptotic cell death in cultured human gastric carcinoma cells. Cancer Res 52:4042-4045
116. Yang YA, Zhang GM, Feigenbaum L, Zhang YE (2006) Smad3 reduces susceptibility to hepatocarcinoma by sensitizing hepatocytes to apoptosis through downregulation of Bcl-2. Cancer Cell 9:445-457
117. Yang J, Song K, Krebs TL, Jackson MW, Danielpour D (2008) Rb/E2F4 and Smad2/3 link survivin to TGF-induced apoptosis and tumor progreβion. Oncogene 27:5326-5338
118. Yokota Y, Mori S (2002) Role of Id family proteins in growth control. J Cell Physiol 190:21-28
119. Yoo J, Ghiaβi M, Jirmanova L, Balliet AG, Hoffman B, Fornace AJ Jr, Liebermann DA, Bottinger EP, Roberts AB (2003) Transforming growth factor-induced apoptosis is mediated by Smaddependent expreβion of GADD45b through p38 activation. J Biol Chem 278:43001-43007